Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$865,216
-$21,317 QoQ
Shares Held
15,431
-16.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#344
of 641 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $3,911,455 across 6 Biotechnology names. RPRX ranks #1 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
15,431 | $865,216 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
2,804 | $799,055 | |
| 3 | EXEL |
Exelixis, Inc.
|
12,392 | $674,248 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,344 | $667,605 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,992 | $480,012 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
5,434 | $425,319 |
All Filings in RPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $865,216 | 15,431 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $886,533 | 18,481 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $634,391 | 16,418 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $502,387 | 14,240 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $407,211 | 11,302 | Shares | Sole | 2025-08-13 | |
| 2022-12-31 | $391,050 | 9,895 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $397,581 | 9,895 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||